Roche GRI Content Index
GRI Content Index 2022
For the Content Index - Advanced Service, GRI Services reviewed that the content index is clearly presented, in a manner consistent with the Standards, and that the references for all disclosures are included correctly and aligned with the appropriate sections in the body of the report.
Statement of use
GRI 1 used
Applicable GRI Sector Standard
F. Hoffmann-La Roche Ltd has reported in accordance with the GRI Standards for the period of 1 January to 31 December 2022 in accordance with the GRI Standards.
GRI 1: Foundation 2021
No sector standards apply.
Disclosure
GENERAL DISCLOSURES
2-1
2-2
2-3
2-4
2-5
2-6
2-7
2-8
2-9
2-10
2-11
2-12
2-13
2-14
2-15
2-16
2-17
2-18
2-19
2-20
2-21
2-22
2-23
2-24
2-25
2-26
2-27
2-28
2-29
2-30
MATERIAL TOPICS
3-1
3-2
Economic performance (Roche material topic: Long-term mindset)
3-3
201-1
201-2
201-3
201-4
Market presence (Roche material topic: Long-term mindset)
3-3
202-1
202-2
Indirect economic impacts (Roche material topics: Affordability of healthcare; Sustainable healthcare systems; Availability of healthcare; Patient centricity)
3-3
203-1
203-2
Procurement practices (Roche material topic: Ethics & transparency)
3-3
204-1
Anti-corruption
3-3
205-1
205-2
205-3
Anti-competitive behavior (Roche material topic: Compliance)
3-3
206-1
Tax (Roche material topic: Compliance)
3-3
207-1
207-2
207-3
207-4
Materials
3-3
301-1
301-2
301-3
Energy (Roche material topic: Energy efficiency)
3-3
302-1
302-2
302-3
302-4
302-5
Water and effluents
3-3
303-1
303-2
303-3
303-4
303-5
Biodiversity
3-3
304-1
304-2
304-3
304-4
Emissions
3-3
305-1
305-2
305-3
305-4
305-5
305-6
305-7
Waste
3-3
306-1
306-2
306-3
306-4
306-5
Supplier environmental assessment
3-3
308-1
308-2
Employment (Roche material topics: Organizational agility; Talent attraction & retention)
3-3
401-1
401-2
401-3
Labor/management relations
401-3
402-1
Occupational health and safety (Roche material topic: Talent attraction & retention)
3-3
403-1
403-2
403-3
403-4
403-5
403-6
403-7
403-8
403-9
403-10
Training and education (Material topic: Talent attraction & retention)
3-3
404-1
404-2
404-3
Diversity and equal opportunity (Roche material topics: Preparedness for aging society; Talent attraction & retention; Organisational agility)
3-3
405-1
405-2
Non-discrimination (Roche material topic: Human rights)
3-3
406-1
Freedom of association and collective bargaining (Roche material topic: Ethics & transparency)
3-3
407-1
Child labor (Roche material topic: Ethics & transparency)
3-3
408-1
Forced or compulsory labor (Roche material topic: Ethics & transparency)
3-3
409-1
Security practices
3-3
410-1
Rights of indigenous peoples (Roche material topic: Human rights)
3-3
411-1
Local communities
3-3
413-1
413-2
Supplier social assessment (Roche material topic: Ethics & transparency)
3-3
414-1
414-2
Public policy
3-3
415-1
Customer health and safety (Roche material topics: Product safety; Product quality)
3-3
416-1
416-2
Marketing and labeling
3-3
417-1
417-2
417-3
Customer privacy (Roche material topic: Data privacy)
3-3
418-1
Roche material topic: Personalised healthcare
3-3
Roche material topic: Real-world data
3-3
Roche material topic: Cyber security
3-3
Roche material topic: R&D efficiency
3-3
GRI Standard
Organizational details
Entities included in the organization’s sustainability reporting
Reporting period, frequency and contact point
Restatements of information
External assurance
Activities, value chain and other business relationships
Employees
Workers who are not employees
Governance structure and composition
Nomination and selection of the highest governance bodyChair of the highest governance body
Chair of the highest governance body
Role of the highest governance body in overseeing the management of impacts
Delegation of responsibility for managing impacts
Role of the highest governance body in sustainability reporting
Conflicts of interest
Communication of critical concerns
Collective knowledge of the highest governance body
Evaluation of the performance of the highest governance body
Remuneration policies
Process to determine remuneration
Annual total compensation ratio
Statement on sustainable development strategy
Policy commitments
Embedding policy commitments
Processes to remediate negative impacts
Mechanisms for seeking advice and raising concerns
Compliance with laws and regulations
Membership associations
Approach to stakeholder engagement
Collective bargaining agreements
Process to determine material topics
List of material topics
Management of material topics
Direct economic value generated and distributed
Financial implications and other risks and opportunities due to climate change
Defined benefit plan obligations and other retirement plans
Financial assistance received from government
Management of material topics
Ratios of standard entry level wage by gender compared to local minimum wage
Proportion of senior management hired from the local community
Management of material topics
Infrastructure investments and services supported
Significant indirect economic impacts
Management of material topics
Proportion of spending on local suppliers
Management of material topics
Operations assessed for risks related to corruption
Communication and training about anti-corruption policies and procedures
Confirmed incidents of corruption and actions taken
Management of material topics
Legal actions for anti-competitive behavior, anti-trust, and monopoly practices
Management of material topics
Approach to tax
Tax governance, control, and risk management
Stakeholder engagement and management of concerns related to tax
Country-by-country reporting
Management of material topics
Materials used by weight or volume
Recycled input materials used
Reclaimed products and their packaging materials
Management of material topics
Energy consumption within the organization
Energy consumption outside of the organization
Energy intensity
Reduction of energy consumption
Reductions in energy requirements of products and services
Management of material topics
Interactions with water as a shared resource
Management of water discharge-related impacts
Water withdrawal
Water discharge
Water consumption
Management of material topics
Operational sites owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas
Significant impacts of activities, products and services on biodiversity
Habitats protected or restored
IUCN Red List species and national conservation list species with habitats in areas affected by operations
Management of material topics
Direct (Scope 1) GHG emissions
Energy indirect (Scope 2) GHG emissions
Other indirect (Scope 3) GHG emissions
GHG emissions intensity
Reduction of GHG emissions
Emissions of ozone-depleting substances (ODS)
Nitrogen oxides (NOx), sulfur oxides (SOx), and other significant air emissions
Management of material topics
Waste generation and significant waste-related impacts
Management of significant waste-related impacts
Waste generated
Waste diverted from disposal
Waste directed to disposal
Management of material topics
New suppliers that were screened using environmental criteria
Negative environmental impacts in the supply chain and actions taken
Management of material topics
New employee hires and employee turnover
Benefits provided to full-time employees that are not provided to temporary or part-time employees
Parental leave
Management of material topics
Minimum notice periods regarding operational changes
Management of material topics
Occupational health and safety management system
Hazard identification, risk assessment, and incident investigation
Occupational health services
Worker participation, consultation, and communication on occupational health and safety
Worker training on occupational health and safety
Promotion of worker health
Prevention and mitigation of occupational health and safety impacts directly linked by business relationships
Workers covered by an occupational health and safety management system
Work-related injuries
Work-related ill health
Management of material topics
Average hours of training per year per employee
Programs for upgrading employee skills and transition assistance programs
Percentage of employees receiving regular performance and career development reviews
Management of material topics
Diversity of governance bodies and employees
Ratio of basic salary and remuneration of women to men
Management of material topics
Incidents of discrimination and corrective actions taken
Management of material topics
Operations and suppliers in which the right to freedom of association and collective bargaining may be at risk
Management of material topics
Operations and suppliers at significant risk for incidents of child labor
Management of material topics
Operations and suppliers at significant risk for incidents of child labor
Management of material topics
Operations and suppliers at significant risk for incidents of forced or compulsory labor
Management of material topics
Incidents of violations involving rights of indigenous peoples
Management of material topics
Operations with local community engagement, impact assessments, and development programs
Operations with significant actual and potential negative impacts on local communities
Management of material topics
New suppliers that were screened using social criteria
Negative social impacts in the supply chain and actions taken
Management of material topics
Political contributions
Management of material topics
Assessment of the health and safety impacts of product and service categories
Incidents of non-compliance concerning the health and safety impacts of products and services
Management of material topics
Requirements for product and service information and labeling
Incidents of non-compliance concerning product and service information and labeling
Incidents of non-compliance concerning marketing communications
Management of material topics
Substantiated complaints concerning breaches of customer privacy and losses of customer data
Management of material topics
Management of material topics
Management of material topics
Management of material topics
Location
Annual Report 2022 p.30 (view 'Reporting Scope and Boundaries')
Basis for Preparation of Non-financial Information 2022 (view '2. Scope (Overall)')
Basis for Preparation of Non-financial Information 2022 (view '2. Scope (Overall)')
Annual Report 2022 p.30 (view 'Reporting Scope and Boundaries')
Basis for Preparation of Non-financial Information 2022 (view '2. Scope (Overall)')
Basis for Preparation of Non-financial Information 2022 (view '2. Scope (Overall)')
Non-financial Reporting (view footnotes at bottom of page)
N/A
Governance (view 'Details of Roche governance structure')
Our Approach to Sustainability (view 'Our sustainability governance structure')
Roche Corporate Sustainability Charter
Our Approach to Sustainability (view 'Our sustainability governance structure')
Roche Corporate Sustainability Charter
Governance (view 'Details of Roche governance structure')
Governance (view 'Details of Roche governance structure')
Our Approach to Sustainability (view 'Our sustainability governance structure')
Our Approach to Sustainability (view 'Our sustainability governance structure')
Governance (view 'Details of Roche governance structure')
Our Approach to Sustainability (view 'Our sustainability governance structure')
Our Approach to Sustainability (view 'Our sustainability governance structure')
Our Approach to Sustainability (view 'Our sustainability governance structure')
Behaviour in Business (view 'Conflict of Interest')
Roche Group Code of Conduct (view 'Conflict of Interest')
Roche Group Code of Conduct (view 'Conflict of Interest')
Our Approach to Sustainability (view 'Our sustainability governance structure')
Board of Directors (view 'Board of Directors' Independence - Performance Assessment')
Remuneration Report 2022 (view '1. Principles')
Remuneration Report 2022 (view '2. Remuneration decision process and approval framework')
Remuneration Report 2022 (view '3. Remuneration components')
Sustainability at Roche
Our Approach to Sustainability (view 'Our sustainability governance structure')
Annual Report 2022 (view 'Reporting & strategy')
Our Approach to Sustainability (view 'Our sustainability governance structure')
Annual Report 2022 (view 'Reporting & strategy')
Sustainability at Roche
Meeting High Standards of Business Ethics
Behaviour in Business (view 'Business Integrity')
Meeting High Standards of Business Ethics
Behaviour in Business (view 'Business Integrity')
Roche Group Code of Conduct (view 'Process for Adequate Handling of Non-Compliant Cases')
Roche Group Code of Conduct (view ''Comprehensive Compliance Management")
Roche Group Code of Conduct (view ''Comprehensive Compliance Management")
Behaviour in Business (view 'Questions and Reporting
Non-compliance')
Roche Group Code of Conduct (view 'Comprehensive Compliance Management')
Roche Group Code of Conduct (view 'Comprehensive Compliance Management')
Our Approach to Public Policy
Working with Patient Organisations
Collaborating with Patient Groups and Patients (Directive)
Roche Memberships and International CR Recommendations
Working with Patient Organisations
Collaborating with Patient Groups and Patients (Directive)
Roche Memberships and International CR Recommendations
Roche Supplier Code of Conduct
Roche Group Employment Policy (view 'Comprehensive Compliance Management')
Roche Group Employment Policy (view 'Comprehensive Compliance Management')
Materiality Assessment and Stakeholder Engagement (view 'Our approach')
Materiality Assessment and Stakeholder Engagement (view 'Our 19 material topics')
Materiality Assessment and Stakeholder Engagement (view 'Long-term mindset')
Non-Financial Reporting (view 'Our economic impact KPIs')
Finance Report 2022 (view p.37 'Pensions and other post-employment benefits')
Finance Report 2022 (view p.57 'Government and regulatory mandatory price reductions - section: Pharmaceuticals Division sales gross-to-net reconciliation')
Materiality Assessment and Stakeholder Engagement (view 'Long-term mindset')
N/A
N/A
Materiality Assessment and Stakeholder Engagement (view 'Affordability of healthcare; Sustainable healthcare systems; Availability of healthcare; Patient centricity')
Procurement Goals & Performance
Supplier Risk Management (view 'Our supplier risk process')
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
Supplier Risk Management (view 'Our supplier risk process')
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
Procurement Goals & Performance (view 'Spend analysis')
Behavior in Business (view 'Dealing with Business Partners')
Anti-Corruption Compliance Questionnaire for Roche Business Partners
Roche Supplier Code of Conduct (view p.5 'Ethics')
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
Anti-Corruption Compliance Questionnaire for Roche Business Partners
Roche Supplier Code of Conduct (view p.5 'Ethics')
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
Behavior in Business (view 'Business Integrity')
United Nations Global Compact (UNGC) Communication on Progress (view p.9 'Anti-corruption')
Directive on Mandatory Global Behaviour in Business eLearning Programs
United Nations Global Compact (UNGC) Communication on Progress (view p.9 'Anti-corruption')
Directive on Mandatory Global Behaviour in Business eLearning Programs
Non-Financial Reporting (view 'Our social impact KPIs - Employees, Suppliers')
Annual Report 2022 (view p. 119 'Environment')
Resources and Raw Materials
SHE Goals & Performance (view 'Environmental Goals')
Resources and Raw Materials
SHE Goals & Performance (view 'Environmental Goals')
N/A
N/A
Annual Report 2022 (view p. 119 'Environment')
Resources and Raw Materials
SHE Goals & Performance (view 'Environmental Goals')
Materiality Assessment and Stakeholder Engagement (view 'Energy efficiency')
Resources and Raw Materials
SHE Goals & Performance (view 'Environmental Goals')
Materiality Assessment and Stakeholder Engagement (view 'Energy efficiency')
Non-Financial Reporting (view 'Our environmental impact KPIs - Total Energy Consumption")
Non-Financial Reporting (view 'Our environmental impact KPIs - Total Energy Consumption')
Managing Value Chain Environmental Impact
Managing Value Chain Environmental Impact
Non-Financial Reporting (view 'Our environmental impact KPIs - Energy intensity')
SHE Goals and Performance (view 'Environmental Goals')
SHE Goals and Performance (view 'Environmental Goals')
Annual Report 2022 (view p. 119 'Environment')
Resources and Raw Materials
Minimize the Environmental Footprint
SHE Goals & Performance (view 'Environmental Goals')
Resources and Raw Materials
Minimize the Environmental Footprint
SHE Goals & Performance (view 'Environmental Goals')
Annual Report 2022 (view p.129 'Environment - Water usage and discharge')
Non-Financial Reporting (view 'Our environmental impact KPIs - Organic matter discharged and Heavy metals discharged')
Annual Report 2022 (view p.129 'Environment - Water usage and discharge')
Annual Report 2022 (view p.129 'Environment - Water usage and discharge')
Non-Financial Reporting (view 'Our environmental impact KPIs - Water consumption')
Annual Report 2022 (view p.129 'Environment - Water usage and discharge')
Annual Report 2022 (view p.129 'Environment - Water usage and discharge')
Annual Report 2022 (view p. 119 'Environment')
Roche Position on Biodiversity
SHE Goals & Performance (view 'Environmental Goals')
Roche Position on Biodiversity
SHE Goals & Performance (view 'Environmental Goals')
Recycling and Waste Management (view 'Projects where Roche is actively involved')
Kesslergrube Remediation Site (in German)
Kesslergrube Remediation Site (in German)
Recycling and Waste Management (view 'Projects where Roche is actively involved')
Kesslergrube Remediation Site (in German)
Kesslergrube Remediation Site (in German)
Annual Report 2022 (view p. 119 'Environment')
Resources and Raw Materials
Minimize the Environmental Footprint
Roche Position on Preventing and Reducing Pollution
Roche Position on Energy
Roche Position on Greenhouse Gases and Climate Change
Roche Position on Pharmaceuticals in the Environment (PiE)
SHE Goals & Performance (view 'Environmental Goals')
Resources and Raw Materials
Minimize the Environmental Footprint
Roche Position on Preventing and Reducing Pollution
Roche Position on Energy
Roche Position on Greenhouse Gases and Climate Change
Roche Position on Pharmaceuticals in the Environment (PiE)
SHE Goals & Performance (view 'Environmental Goals')
Non-Financial Reporting (view 'Our environmental impact KPIs - Greenhouse Gas Emissions')
Greenhouse Gas Emissions
Greenhouse Gas Emissions
SHE Goals & Performance (view 'Environmental Goals')
SHE Goals & Performance (view 'Environmental Goals')
SHE Goals & Performance (view 'Environmental Goals')
N/A
Annual Report 2022 (view p. 119 'Environment')
Recycling and Waste Management
Minimize the Environmental Footprint
Roche Position on Waste Management and Circular Economy
Roche Position on Landfills / Contaminated Soil
Roche Position on Pharmaceuticals in the Environment (PiE)
SHE Goals & Performance (view 'Environmental Goals')
Recycling and Waste Management
Minimize the Environmental Footprint
Roche Position on Waste Management and Circular Economy
Roche Position on Landfills / Contaminated Soil
Roche Position on Pharmaceuticals in the Environment (PiE)
SHE Goals & Performance (view 'Environmental Goals')
Non-Financial Reporting (view 'Our environmental impact KPIs')
SHE Goals & Performance (view 'Environmental Goals')
SHE Goals & Performance (view 'Environmental Goals')
Sustainability at Roche - Environment (view 'Managing Value Chain Environmental Impact')
Working with Suppliers
Sustainability Principles for Roche Suppliers
Procurement Goals and Performance
Roche Supplier Online Course 'Roche Supplier Code of Conduct' with a lesson 'Environment'
Working with Suppliers
Sustainability Principles for Roche Suppliers
Procurement Goals and Performance
Roche Supplier Online Course 'Roche Supplier Code of Conduct' with a lesson 'Environment'
N/A
N/A
Roche Employment Policy
Materiality Assessment and Stakeholder Engagement (view 'Organisational agility; Talent attraction & retention')
Materiality Assessment and Stakeholder Engagement (view 'Organisational agility; Talent attraction & retention')
Non-Financial Reporting (view 'Our social impact KPIs - Employees')
Finance Report 2022 (view 'Employee benefits')
N/A
N/A
Our Approach to Safety, Security, Health and Environment
Roche Guidelines for the Assurance of Safety, Security, Health and Environmental Protection
Roche Occupational Health and Hygiene Directive
Guide to Mental Health Protection
Materiality Assessment and Stakeholder Engagement (view 'Talent attraction & retention')
Roche Guidelines for the Assurance of Safety, Security, Health and Environmental Protection
Roche Occupational Health and Hygiene Directive
Guide to Mental Health Protection
Materiality Assessment and Stakeholder Engagement (view 'Talent attraction & retention')
Policy on Safety, Security, Health and Environmental Protection (SHE) (view 'SHE Management System')
Directive on Mandatory Global Behaviour in Business eLearning Programs (view 'Roche SHE')
Roche Code of Conduct (view 'Safety, Security, Health & Environment')
Roche Guidelines for the Assurance of Safety, Security, Health and Environmental Protection (view p.26 'Prevention')
N/A
Non-Financial Reporting (view 'Our social impact KPIs - Employees')
Directive on Mandatory Global Behaviour in Business eLearning Programs
Materiality Assessment and Stakeholder Engagement (view 'Talent attraction & retention')
Materiality Assessment and Stakeholder Engagement (view 'Talent attraction & retention')
Non-Financial Reporting (view 'Our social impact KPIs - Employees')
Annual Report 2022 (view p.110- 'Supporting and engaging our people')
N/A
Diversity and Inclusion at Roche
Annual Report 2022 (view pp.199-113 'People and Culture')
We are diverse, we are Global Operations, we are Roche
Materiality Assessment and Stakeholder Engagement (view 'Preparedness for aging society; Talent attraction & retention; Organisational agility')
Annual Report 2022 (view pp.199-113 'People and Culture')
We are diverse, we are Global Operations, we are Roche
Materiality Assessment and Stakeholder Engagement (view 'Preparedness for aging society; Talent attraction & retention; Organisational agility')
N/A
Materiality Assessment and Stakeholder Engagement (view 'Human rights')
Human Rights
Human Rights in the Value Chain
Roche Position on Respecting Human Rights
Roche Code of Conduct (view 'Discrimination and Harassment')
Roche Supplier Code of Conduct (view p.7 'Human Rights and Labor')
Roche Employment Policy
Human Rights
Human Rights in the Value Chain
Roche Position on Respecting Human Rights
Roche Code of Conduct (view 'Discrimination and Harassment')
Roche Supplier Code of Conduct (view p.7 'Human Rights and Labor')
Roche Employment Policy
Roche Employment Policy
Roche Supplier Code of Conduct (view p.7 'Human Rights and Labour')
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
Roche Supplier Code of Conduct (view p.7 'Human Rights and Labour')
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
Human Rights in the Value Chain (view 'Human Rights Findings in 2021' and '2022 Human Rights Risks')
Human Rights (view 'Working conditions')
Human Rights in the Value Chain
Roche Position on Respecting Human Rights
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
Human Rights in the Value Chain
Roche Position on Respecting Human Rights
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
Human Rights in the Value Chain (view 'Human Rights Findings in 2021' and '2022 Human Rights Risks')
Human Rights (view 'Working conditions')
Human Rights in the Value Chain
Roche Position on Respecting Human Rights
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
Human Rights in the Value Chain
Roche Position on Respecting Human Rights
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
Human Rights in the Value Chain (view 'Human Rights Findings in 2021' and '2022 Human Rights Risks')
Materiality Assessment and Stakeholder Engagement (view 'Human rights')
Human Rights
Human Rights in the Value Chain
Sustainability in Procurement Practices
Roche Position on Respecting Human Rights
Human Rights
Human Rights in the Value Chain
Sustainability in Procurement Practices
Roche Position on Respecting Human Rights
N/A
Strengthening Communities
Materiality Assessment and Stakeholder Engagement (view 'Affordability of healthcare; Sustainable healthcare systems; Availability of healthcare')
Materiality Assessment and Stakeholder Engagement (view 'Affordability of healthcare; Sustainable healthcare systems; Availability of healthcare')
N/A
Working with Suppliers
Sustainability in Procurement Practices
Procurement Risk Management
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
Sustainability in Procurement Practices
Procurement Risk Management
Materiality Assessment and Stakeholder Engagement (view 'Ethics & transparency')
N/A
Our Approach to Public Policy (view 'Supporting Associations and Political Institutions')
Protecting Patient Safety
Materiality assessment and Stakeholder Engagement (view 'Product safety, Product quality')
Roche Medical Information (Searchable database for medical information on Roche products)
For Patients Portal (Informational resource for patients, their relatives, caregivers or doctors looking for information in clear and simple language about clinical trials or diseases where Roche/Genentech is doing research or supporting research conducted by others)
Materiality assessment and Stakeholder Engagement (view 'Product safety, Product quality')
Roche Medical Information (Searchable database for medical information on Roche products)
For Patients Portal (Informational resource for patients, their relatives, caregivers or doctors looking for information in clear and simple language about clinical trials or diseases where Roche/Genentech is doing research or supporting research conducted by others)
N/A
N/A
Roche Anticounterfeiting
Anti-Counterfeiting FAQs
Roche Position on Counterfeit and Falsified Pharmaceutical & Diagnostic Products
Anti-Counterfeiting FAQs
Roche Position on Counterfeit and Falsified Pharmaceutical & Diagnostic Products
Annual Report 2022 p.157 (view 'Compliance')
Annual Report 2022 p.157 (view 'Compliance')
Our Commitment to Data Sharing
Roche Global Policy on Sharing of Clinical Study Information
Materiality Assessment and Stakeholder Engagement (view 'Data privacy')
Roche Global Policy on Sharing of Clinical Study Information
Materiality Assessment and Stakeholder Engagement (view 'Data privacy')
Non-Financial Reporting (view 'Our social impact KPIs - Employees - Alleged Business Ethics Incidents')
Materiality Assessment and Stakeholder Engagement (view 'Personalised healthcare')
Materiality Assessment and Stakeholder Engagement (view 'Real-world data')
Materiality Assessment and Stakeholder Engagement (view 'Cyber security')
Materiality Assessment and Stakeholder Engagement (view 'R&D efficiency')
Omission
Omitted (Information unavailable/incomplete): Due to high fluctuation of external workers on our sites, it is difficult to have an exhaustive number of all external forces. This measure is covered as external agencies costs.
Omitted (Information unavailable/incomplete): Roche is not disclosing this measure publicly for confidentiality reason.
Omitted (Information unavailable/incomplete): Roche is currently not disclosing this measure publicly. We are considering reporting on a more granular level in the future.
Omitted (Information unavailable/incomplete): Roche's operations follow high environmental and sustainability standards, but they also generate waste. Roche’s 'Guidelines for the Assurance of Safety, Security Health and Environmental Protection (SHE)' define global waste handling concepts; including the guiding principle, that disposal should be safe and ecologically friendly. All new pharmaceutical and diagnostic product design processes include the evaluation of ways to minimize waste from products and packaging, and encourage the use of recycled or recyclable material.
Measures, such as recycled input materials and packaging materials of recliamed products are currently being assessed.
Omitted (Information unavailable/incomplete): Roche's operations follow high environmental and sustainability standards, but they also generate waste. Roche’s 'Guidelines for the Assurance of Safety, Security Health and Environmental Protection (SHE)' define global waste handling concepts; including the guiding principle, that disposal should be safe and ecologically friendly. All new pharmaceutical and diagnostic product design processes include the evaluation of ways to minimize waste from products and packaging, and encourage the use of recycled or recyclable material.
Measures, such as recycled input materials and packaging materials of recliamed products are currently being assessed.
Omitted (Information unavailable/incomplete): Roche recognises climate change as one of the largest global risks and is committed to addressing it as a matter of urgency. Since the early 2000s Roche has been working towards a low-carbon future. Most GHG emissions at Roche originate from the transformation and use of energy. Therefore, the actions taken to reduce GHGs, such as carbon dioxide, focus on all issues surrounding energy usage, e.g., reducing energy consumption and improving energy intensity.
Emissions of ODS are currently not part of Roche's KPIs but are considered to be included in the future.
Omitted (Information unavailable/incomplete): Roche is currently not specifically disclosing the number of new suppliers that were screened using environmental criteria but are considering disclosing such measure in the future.
Omitted (Information unavailable/incomplete): Roche is currently not specifically disclosing negative environmental impacts in the supply chain but are considering disclosing such measure in the future.
Omitted (Information unavailable/incomplete): Roche is currently not disclosing this measure publicly as our HR systems do not track such measure at a global level. The organization is considering reporting on a more granular level in the future.
Omitted (Information unavailable/incomplete): Roche is currently not disclosing this information publicly, as notice periods are managed locally without global alignment.
Omitted (Information unavailable/incomplete): Roche currently does not have a system in place to track such measure globally.
Omitted (Information unavailable/incomplete): With our focus on natural, long-term growth, Roche depends on the contributions of talented and committed professionals who are determined to drive our progress. In turn, we make sure our work environment supports our employees to follow their personal goals and and pursue their professional development.
Roche is currently not tracking the percentage of employees receiving regular performance and career development at the global level; is considering tracking such measure as part of our KPIs in the future.
Omitted (Information unavailable/incomplete): At Roche, people are at the heart of what we do. We are grounded in a clear and deep sense of purpose and committed to a culture where everyone feels a sense of belonging and where we can thrive equally. We are building a workforce that reflects the global societies we serve by increasing underrepresented nationalities, by providing transparency on our goals and performance and by maintaining gender pay equity.
Roche is currently not tracking the ratio of basic salary and remuneration of women to men at the global level.
In accordance with our company guidelines, training on human rights policies is mandatory for both Roche's and contractors’ employees at all Roche sites (Roche Behavior in Business training module).
Omitted (Information unavailable/incomplete): Roche respects and proactively supports human rights, both in our own operations and our value chain. By applying the principle of ‘knowing and showing’, Roche is committed to avoiding adverse impacts on human rights by focusing on the perspective of the rights holder.
Roche is currently not tracking measures, such as incidents of violations involving the rights of indigenous peoples.
Omitted (Information unavailable/incomplete): Roche is committed to building stronger communities and environments and responding to natural disasters sustainably. We seek to strengthen our connection to local communities with innovative, sustainable projects and partnerships that add value, while respecting local customs and needs.
We currently do not track operations with significant impacts on local communities at a global level.
Omitted (Information unavailable/incomplete): Sustainability is a core element of Roche’s strategy, and central to procurement’s purpose of delivering long term value for the company and our patients. Roche's Sustainability Standards, as outlined in the Supplier Code of Conduct, list our expectations towards suppliers in the areas of ethics, human rights & labour, health & safety, environment and management systems.
We are currently not tracking negative social impacts in the supply chain as part of our KPIs.
Omitted (Information unavailable/incomplete): To ensure that every Roche product is both effective and safe, we have established a systematic process designed to optimise patient safety throughout the lifecycle of a medicine. We collaborate with regulatory agencies, monitor reports of adverse events experienced by patients and communicate on our product safety activities, as appropriate to the audience. Any medicine may cause side effects in some patients. Our priority is to make sure that the therapeutic benefits of the medicine outweigh the risks.
Roche is currently not disclosing measures, such as assessments of health and safety impacts at a global level.
Omitted (Information unavailable/incomplete): Roche is currently not disclosing measures, such as assessments of health and safety impacts at a global level.
Reporting in accordance with GRI Sustainability Reporting Standards
As part of Roche's efforts to advance sustainability reporting, we support the activities of the Global Reporting Initiative (GRI) as a Community member and advocate its mission to empower decision makers worldwide, through the GRI sustainability reporting standards and its multi-stakeholder network to take action towards a more sustainable world.
Roche has been using the Global Reporting Initiative as a guide and reference point since 2005. In 2018/2019, we conducted a